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Runx1 Expression Marks Long-Term
Repopulating Hematopoietic Stem Cells
in the Midgestation Mouse Embryo
in the embryo and where these HSCs are located within
the embryonic tissues from which they emerge are the
questions we addressed in this study.
The formation and/or function of HSCs requires both
the Runx1 (also known as AML1, Cbfa2, and Pebpa2b)
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and Cbfb genes (Okuda et al., 1996; Sasaki et al., 1996;Dartmouth Medical School
Wang et al., 1996a, 1996b). Homozygous disruption ofHanover, New Hampshire 03755
Runx1 or Cbfb does not block the development of primi-2 Department of Cell Biology and Genetics
tive yolk sac-derived erythrocytes. However, definitiveErasmus University
erythrocytes, myeloid cells, and lymphocytes fail to de-Rotterdam
velop, indicating a role for both genes at the level ofThe Netherlands
definitive hematopoietic progenitors or HSCs. Runx1
and Cbfb encode the DNA binding and non-DNA binding
subunits, respectively, of a transcription factor in theSummary
family of core binding factors (CBFs) (Speck and Stacy,
1995). The non-DNA binding CBF subunit is commonHematopoietic stem cells (HSCs) are first found in the
to all three members of the CBF family. Therefore, theaorta-gonad-mesonephros region and vitelline and
developmental specificity of the CBFs is most likely de-umbilical arteries of the midgestation mouse embryo.
termined by differences in the expression and biochemi-Runx1 (AML1), the DNA binding subunit of a core
cal properties of the DNA binding subunits.binding factor, is required for the emergence and/or
Recently, we reported on the expression pattern ofsubsequent function of HSCs. We show that all HSCs
Runx1 in the embryo using mice in which lacZ wasin the embryo express Runx1. Furthermore, HSCs in
knocked into the Runx1 locus (North et al., 1999). Runx1Runx1/ embryos are heterogeneous and include
is expressed in all sites from which hematopoietic cellsCD45 cells, endothelial cells, and mesenchymal cells.
emerge, as well as in several nonhematopoietic sites.Comparison with wild-type embryos showed that the
Runx1 protein is first detected in mesenchymal cells indistribution of HSCs among these various cell popula-
the yolk sac at embryonic age (E) 7.5 and in both primi-tions is sensitive to Runx1 dosage. These data provide
tive erythrocytes and endothelial cells in the yolk sacthe first morphological description of embryonic HSCs
blood islands at E8.0. Runx1 levels decline in primitiveand contribute new insight into their cellular origin.
erythrocytes and almost all endothelial cells by E8.5 but
remain high in a small number of endothelial cells andIntroduction
blood cells scattered throughout the yolk sac blood is-
lands. Also at E8.5, Runx1 expression initiates in threeHematopoietic stem cells (HSCs) are at the base of the
new sites: in mesenchymal cells at the distal tip of thedefinitive hematopoietic hierarchy and give rise to all
allantois, in endothelial cells in the vitelline artery, andhematopoietic lineages in the adult organism. The work-
in endothelial cells in the ventral portion of the paireding definition of an HSC is a cell that can provide long-
dorsal aortae within what will become the AGM region.term multilineage hematopoietic reconstitution when
Between E9.5 and E11.5, Runx1 is expressed in endo-transplanted into an adult animal and can self-renew.
thelial cells in the VU arteries, in both endothelial cellsHSCs in the adult animal reside in the bone marrow.
and mesenchymal cells in the ventral portion of the AGM
However, studies in the mouse embryo have shown that
region, and in a small number of endothelial cells in the
the first HSCs are found before bone or bone marrow
yolk sac, but in no other endothelial cells in the embryo.
is formed, in the dorsal aorta within the aorta-gonad- Shortly after the onset of endothelial cell expression,
mesonephros (AGM) region and in two arteries that con- clusters of Runx1 cells can be seen inside the lumina
nect the dorsal aorta to the yolk sac and placenta, and of the dorsal aorta, the VU arteries, and yolk sac that
the vitelline and umbilical (VU) arteries (de Bruijn et are closely associated with the Runx1 endothelium.
al., 2000; Medvinsky and Dzierzak, 1996; Mu¨ller et al., Intraaortic clusters have been seen at a similar develop-
1994). Grafting experiments in frog and avian embryos mental time in the embryos of many organisms (Marshall
likewise identified an intraembryonic region analogous and Thrasher, 2001). Cells in the clusters are rounded
to the mouse AGM as a source of the adult hematopoi- in appearance and express the pan-leukocyte marker
etic system (Cormier and Dieterlen-Lievre, 1988; Die- CD45, indicating that they are hematopoietic cells (Jaf-
terlen-Lie`vre, 1975; Turpen and Knudson, 1982). Also, fredo et al., 1998; Tavian et al., 1996). Lineage-tracing
in chick embryos, the allantois, which contributes to the studies in chick embryos suggest that the intraaortic
formation of the umbilical artery, was shown to be a hematopoietic clusters form from the endothelial cells
potent source of blood cell precursors (Caprioli et al., in these arteries (Jaffredo et al., 1998, 2000). Intraaortic
1998). HSCs are also found in the yolk sac and in the clusters and CD45 cells are absent in Runx1 deficient
fetal liver 1 day after they appear in the AGM region and embryos (North et al., 1999; Takakura et al., 2000; Yo-
VU arteries. The types of cells that function as HSCs komizo et al., 2001), suggesting that Runx1 specifies a
subset of endothelial cells to form intraaortic clusters.
Both genetic and histological studies suggest that3 Correspondence: nancy.speck@dartmouth.edu
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Figure 1. HSCs in the Midgestation Mouse Embryo Express Runx1
(A) Experimental design. E10.5 to 12.5 embryos were generated by crossing Runx1lz/ male mice with wild-type female mice. Tissues from
Runx1/ and Runx1lz/ embryos were isolated by dissection, pooled according to their genotype, and dispersed with collagenase to create
single-cell suspensions. Cells were loaded with the -galactosidase substrate fluorescein di--D-galactopyranoside (FDG). Cells from Runx1/
embryos were used to set sort gates, and cells from Runx1lz/ embryos were separated into Runx1 and Runx1 populations on the basis of
green fluorescence intensity by fluorescence-activated cell sorting (FACS) (Nolan et al., 1988). Runx1 or Runx1 cells were injected into
irradiated adult recipient mice, and peripheral blood and bone marrow was assayed for the presence of donor-derived cells 4 months
posttransplantation.
(B) Representative FACS profiles of E11.5 AGM region and VU artery cells from Runx1/ and Runx1lz/ embryos incubated with FDG. Dead
cells were excluded on the basis of Hoechst 33258 uptake. Percentages of live cells in both the Runx1 and Runx1 sort regions are indicated,
and samples from the purified populations obtained from Runx1lz/ embryos are shown.
(C) PCR samples of peripheral blood DNA from adult recipient mice at 4 months posttransplantation. Lanes: 1, molecular weight standard; 2–5,
blood samples from two successfully repopulated (2 and 5) and nonrepopulated (3 and 4) primary (1) transplant recipients; 6 and 7, control spleen
DNA from a Runx1lz/ and Runx1/ mouse, respectively. PCR products from the lacZ gene and myogenin (an internal control) are indicated.
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Runx1 expression marks the first definitive hematopoi- 14/20 transplanted mice (Figure 1F). In contrast, 0/20
mice were reconstituted with Runx1 cells. We per-etic progenitors and HSCs in the embryo, but this has
not been directly demonstrated. Furthermore, Runx1 is formed the same analysis with AGM region and VU
artery cells from E10.5 Runx1lz/ embryos (Figure 1D)expressed in several distinct cell types in embryonic
hematopoietic tissues, but which cell types include the and again observed hematopoietic reconstitution only
with Runx1 cells (Figure 1F). Runx1 and Runx1 cellsprogenitors or HSCs is not known. Here we show by
transplantation assays that all HSCs in the AGM region, were also isolated from the fetal liver at E12.5 and trans-
planted with similar results (Figures 1D and 1F). MiceVU arteries, and fetal liver are within the Runx1 popu-
lation of cells. Furthermore, we show that in embryos transplanted with E11.5 and E12.5 Runx1 cells showed
high levels of multilineage engraftment (Figures 1E andwith only one functional Runx1 allele, HSCs are present
in the Runx1 mesenchymal, endothelial, and CD45 1F). Donor-derived bone marrow cells from primary
transplant recipients were able to reconstitute hemato-cell populations. In wild-type embryos, however, a mes-
enchymal HSC population is not detectable at the same poiesis in secondary recipients (data not shown), dem-
onstrating that the Runx1 cell population in the AGMdevelopmental stage, and endothelial HSCs are much
less prevalent. These data indicate that embryonic HSCs region and VU arteries contains bona fide HSCs. Thus,
in each of the hematopoietic tissues we tested, all HSCsare phenotypically heterogeneous and that the distribu-
tion of HSCs between the CD45, endothelial, and mes- were in the Runx1 population of cells, and no HSCs
were found among the Runx1 cells.enchymal cell populations is sensitive to Runx1 dosage.
Results HSCs are CD45 and CD45
To determine which of the Runx1 cells contained HSC
activity, we used antibodies against cell surface markersHSCs from the Midgestation Mouse Embryo
Express Runx1 to further segregate the Runx1 cells by FACS. Expres-
sion of the cell surface markers was also examined inWe previously generated a Runx1 allele (Runx1lz) in
which several 3 exons were replaced with lacZ se- histological sections with the same antibodies used for
cell sorting to pinpoint the location of each cell popula-quences (North et al., 1999). The Runx1lz allele encodes
a Runx1--galactosidase fusion protein that contains tion within the embryonic tissues.
CD45 is a pan-leukocyte marker expressed on all he-an intact Runx1 DNA binding domain and nuclear local-
ization sequences but lacks sequences required for matopoietic cells except erythrocytes (Ledbetter and
Herzenberg, 1979; van Ewijk et al., 1981). CD45 cellstransactivation. Runx1lz is a nonfunctional Runx1 allele,
and since several stages of hematopoiesis are sensitive were found scattered throughout E11.5 Runx1lz/ em-
bryos and in the AGM region were located primarily into Runx1 dosage (Cai et al., 2000; Hayashi et al., 2000;
Mukouyama et al., 2000; Song et al., 1999; Wang et al., the paraaortic mesenchyme (Figure 2A). CD45 cells
were also found in intraaortic hematopoietic clusters1996a, 1996b), the Runx1lz/ mice are haploinsufficient
for Runx1. (Jaffredo et al., 1998; Tavian et al., 1996) (data not
shown) and occasionally in the circulation (data notTo determine whether Runx1 is expressed in HSCs,
we isolated Runx1 and Runx1 cells from the AGM shown). In general, there are fewer intraaortic hemato-
poietic clusters at E11.5 than at E10.5 (Garcia-Porrero etregion, VU arteries, and fetal livers of Runx1lz/ em-
bryos and performed adoptive transfer experiments, as al., 1995), and Runx1 haploinsufficiency further reduces
their size and number (Cai et al., 2000). All of the CD45outlined in Figure 1A. We were unable to analyze Runx1
and Runx1 yolk sac cells because background fluores- cells we observed in histological sections, including
CD45 cells in the paraaortic mesenchyme and scat-cence was too high in the yolk sac to detect a specific
signal from the Runx1lz allele (data not shown). Most tered throughout the embryo, appear to express Runx1.
However, the converse is not true, as there are Runx1of our experiments were performed at E11.5 since the
frequency of HSCs is higher than at E10.5 (Mu¨ller et al., mesenchymal cells and endothelial cells that do not
express CD45 (Figure 2A).1994). Runx1 cells constitute approximately 13% to
30% of cells isolated from the pooled AGM region and We transplanted CD45 and CD45 cells (Figure 2B)
from the AGM region and VU arteries of E11.5 Runx1lz/VU arteries of E11.5 Runx1lz/ embryos (Figure 1B).
Upon transplantation of one embryo equivalent (ee) of embryos into mice and found HSC activity in both popu-
lations (Figure 2D). We also isolated Runx1CD45 cellsRunx1 cells into individual recipient mice, donor-
derived cells were detected in the peripheral blood of and Runx1CD45 cells (Figure 2C) and again found
(D) Runx1 (FDG) expression in E10.5 AGM region and VU artery cells and E12.5 fetal liver cells of Runx1lz/ embryos. Representative
percentages in each sort window are indicated.
(E) Multilineage analysis (as described in Experimental Procedures) of bone marrow cells isolated from a Runx1lz/ and a 1 transplant recipient
mouse. The total percentage of donor cells in bone marrow of this particular recipient was 31.0%. Double-positive cells in the upper right
quadrant document contribution to each lineage.
(F) Transplantation results. Data are the total of 13 experiments. One ee of AGM and VU cells or 0.1 ee of fetal liver cells was transplanted
per recipient. Reconstitution data were determined by PCR amplification of peripheral blood DNA at 4 months posttransplantation (C) and
confirmed by FACS analysis of bone marrow cells (E). In all cases, multilineage reconstitution was demonstrated. 1Secondary transplants
were successfully performed. Relative sizes of the sorted subsets were (mean % viable cells [range]): E10.5 AGM, VU Runx1 10.2%
(6.8–13.9), Runx1 78.9% (71.4–88.7); E11.5 AGM, VU Runx1 19.8% (12.8–29.5), Runx1 65.5% (51.6–81.3); E12.5 fetal liver Runx1 53.5%
(44.2–63.6), Runx1 29.0% (20.5–35.5).
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HSCs in both populations (Figure 2D). HSCs in fetal livers (Figure 3A) and VU arteries (data not shown) but did
not label the Runx1 mesenchymal cells. Five to twelvefrom E12.5 Runx1lz/ embryos were likewise found in
percent of AGM region and VU cells were positive forboth populations. In the AGM region and VU arteries
CD31, Flk-1, or VE-cadherin by FACS (Figure 3A andfrom E10.5 Runx1lz/ embryos, we found HSCs in the
Table 1), and on average 27% of CD31, Flk1, or VE-CD45 population only, suggesting that CD45 HSCs
Cad cells also expressed Runx1 (data not shown). Inare more abundant than CD45 HSCs at E10.5.
all cases, we found HSCs in both positive (CD31, Flk1,We also examined the expression of CD45 on HSCs
or VE-Cad) and negative populations of cells from thefrom Runx1/ embryos. CD45 and CD45 cells were
AGM region and VU arteries of Runx1lz/ embryos (Ta-isolated from Runx1/ embryos that carried a human
ble 1). Fractionation of Runx1 cells into CD31, Flk-1,-globin transgene (Strouboulis et al., 1992) or were
or VE-cadherin positive and negative populations alsoheterozygous for an insulin receptor substrate 3 (Irs3)
revealed HSCs in both populations (Table 1).gene deletion (Liu et al., 1999) to mark the donor-derived
As many endothelial cell markers are also found oncells. A larger proportion of HSCs resides in the CD45
cells within the intraaortic clusters (Marshall andcell population of the AGM region, VU arteries, and
Thrasher, 2001), we used antibodies to CD31 or VE-fetal liver of Runx1/ embryos versus Runx1lz/ embryos
cadherin in conjunction with antibodies to CD45 to sepa-(Figure 2D). Also, the percentage of CD45 cells in the
rate endothelial cells from the hematopoietic clustersE11.5 AGM region and VU arteries was approximately
(Figures 3B and 3C). We found that CD31CD45 and2- to 3-fold higher in Runx1/ embryos than in Runx1lz/
VE-CadCD45 cells from the AGM region and VUembryos (Figures 2B and 2D). Thus, Runx1 dosage af-
arteries of Runx1lz/ embryos contained HSCs (Tablefects both the percentage of CD45 cells and the distri-
2), indicating that some HSCs in Runx1lz/ embryos arebution of HSCs between the CD45 and CD45 popula-
CD45 endothelial cells.tions.
Since some HSCs in Runx1lz/ embryos were CD45
and some did not express endothelial cell markers, we
Runx1 Endothelial and Mesenchymal Cells Are HSCs determined whether these HSCs were mesenchymal
The data suggest that some HSCs in the AGM region cells. We gated on the Runx1 fraction of AGM region
and VU arteries of Runx1lz/ embryos are CD45 endo- and VU artery cells and separated the cells that ex-
thelial cells or mesenchymal cells; thus, we used anti- pressed VE-cadherin alone, CD45 alone, or coex-
bodies recognizing several different endothelial cell sur- pressed both markers from Runx1 cells that expressed
face markers, including CD31, Flk-1, and VE-cadherin, neither VE-cadherin nor CD45 (Figure 3D), which should
to determine if cells expressing these markers have HSC represent Runx1 mesenchymal cells. We found that
activity. CD31 (or platelet/endothelial cell adhesion mol- hematopoiesis in 6/9 mice transplanted with Runx1VE-
ecule, PECAM-1) is reportedly expressed on all endothe- CadCD45 cells was reconstituted with donor-derived
lial cells in the embryo but not on angioblasts (Drake cells (Table 2), leading us to conclude that at least some
and Fleming, 2000). CD31 is also found on bone marrow HSCs in Runx1lz/ embryos are mesenchymal cells. In
HSCs (van der Loo et al., 1995) and on intraaortic clus- contrast, we found no hematopoietic reconstitution with
ters (Garcia-Porrero et al., 1998). Flk-1 was cloned from VE-Cad, CD31 (Table 1), or VE-CadCD45 (Table
fetal liver hematopoietic cells and is expressed on endo- 2) populations of cells from the AGM region and VU
thelial cell progenitors and endothelial cells (Drake and arteries of E11.5 Runx1/ embryos. Therefore, E11.5
Fleming, 2000; Matthews et al., 1991; Shalaby et al., Runx1/ embryos do not appear to contain detectable
1997; Yamaguchi et al., 1993). Flk-1 is expressed in mesenchymal HSCs, although we cannot rule out the
intraaortic hematopoietic clusters in mouse embryos, possibility that very low numbers of these HSCs are
as visualized by intracellular X-gal staining in Flk-1lz/ present. Most, if not all, HSCs in E11.5 Runx1/ em-
embryos (Shalaby et al., 1997) but not in chick embryos bryos expressed the endothelial markers VE-cadherin
as detected by immunohistology (Jaffredo et al., 1998). and CD31, in addition to CD45, and we conclude that
VE-cadherin is expressed on endothelial cells in the dor- most HSCs in E11.5 Runx1/ embryos are within the
sal aorta and major blood vessels in a pattern similar hematopoietic clusters. We did find hematopoietic re-
to CD31 (Drake and Fleming, 2000). constitution with the Flk-1 population from Runx1/
Antibodies to CD31, Flk1, and VE-cadherin appeared embryos (Table 1). However, cell surface Flk-1 is down-
regulated on the CD45 intraaortic clusters in chick em-to uniformly label all endothelial cells in the AGM region
Figure 2. HSCs Are CD45 and CD45
(A) Transverse sections (10 and 60 magnification) through the AGM regions of E11.5 Runx1lz/ embryos incubated with X-gal (blue) to
visualize Runx1 expression and stained with an antibody to CD45 to detect hematopoietic cells (brown). Region in right panel is outlined in
left panel. Ao, aortic lumen. Note in 60 panel that CD45 cells are also Runx1.
(B) Comparison of CD45 expression on E11.5 AGM region and VU artery cells from Runx1/ and Runx1lz/ embryos. Representative
percentages and sort regions used in transplantation studies are indicated.
(C) Dot plot of CD45 and Runx1 expression of AGM region and VU artery cells with sort gates and relevant controls.
(D) Transplantation results: 1one ee of AGM region and VU cells and 0.1 ee of fetal liver cells was transplanted per recipient; 2reconstitution
data were determined by PCR amplification of peripheral blood DNA at 1 and 4 months posttransplantation; data are the total of 15 experiments;
3 the extent of reconstitution for mice transplanted with Runx1lz/ donor cells was determined by FACS analysis of bone marrow; in all cases
multilineage reconstitution was demonstrated; 4 secondary transplants were performed and reconstitution demonstrated; 5 although the purity
of the CD45 population was 95%, repopulation by contaminating CD45 cells cannot be ruled out.
Immunity
666
Figure 3. Endothelial Markers on HSCs
(A) (Top) FACS profiles of E11.5 Runx1lz/ AGM region and VU artery cells incubated with antibodies to CD31, Flk1, and VE-cadherin.
Representative cell distribution and sort regions are shown. (Bottom) Transverse sections of the AGM region from an E11.5 Runx1lz/ embryo
incubated with X-gal alone (blue), or double-stained for Runx1 (blue) and CD31, Flk-1, or VE-cadherin (brown). Arrows indicate hematopoietic
clusters. Note that in Flk-1-stained sections the hematopoietic clusters do not appear to express Flk-1.
(B and C) Fractionation of CD31 positive (B) or VE-cadherin (C) positive Runx1lz/ endothelial cells based on CD45 expression. Sort gates are
indicated.
(D) Isolation of Runx1 mesenchymal cells based on the absence of cell surface VE-cadherin and CD45, measured in the same channel.
bryos (Jaffredo et al., 1998), and this also appears to Expression of the Adult HSC Markers Sca-1 and c-kit
Finally, we examined the expression of two other mark-be the case in mouse (Figure 3A). This suggests that
the Flk-1population of HSCs is localized to the hemato- ers found on HSCs in adult bone marrow, Sca-1 and
c-kit (Morrison et al., 1995; Spangrude et al., 1988). Cellpoietic clusters.
We also examined whether CD31, Flk-1, and VE-cadh- surface Sca-1 marks a subset of HSCs from the AGM
regions of E11.5 wild-type embryos (de Bruijn et al.,erin are expressed on E12.5 fetal liver HSCs. CD31 was
found on all E12.5 fetal liver HSCs in both Runx1lz/ and 2002 [this issue of Immunity]), and c-kit was shown to
mark all HSCs in both the AGM region and fetal liverRunx1/ embryos (Table 1). Flk-1 and VE-cadherin, on
the other hand, were found on only a small proportion (Sanchez et al., 1996). Approximately 16% of AGM re-
gion and VU artery cells was Sca-1, and Runx1 wasof fetal liver HSCs. Thus, HSCs appear to retain CD31
(a finding that is in agreement with CD31 expression expressed in approximately one-third of Sca-1 cells
(Figure 4A). We found HSCs in both the Sca-1 and Sca-by adult bone marrow HSCs) but to downregulate cell
surface VE-cadherin soon after they emerge. 1 populations of the AGM region and VU artery cells
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Table 1. Expression of Endothelial Cell Markers on HSCs
# Reconstituted2
Embryonic Embryonic Cell
% of Total Viable Cells (Range)Tissue Age Population1 #Transplanted
Runx1/ Runx1lz/ Runx1/ Runx1lz/ % Reconstitution3
AGM, VU 10.5 CD31 8.8 (6.9–9.9) 1/10 5%
AGM, VU 10.5 CD31 74.4 (69.7–79.7) 2/10 5%
AGM, VU 11.5 CD31 17.3 (15.6–19.2) 8.5 (6.6–12.1) 5/17 2/8 10%–11%
AGM, VU 11.5 CD31 81.0 (78.7–82.9) 75.5 (71.2–80.5) 0/14 6/8 12%–33%
AGM, VU4 11.5 Runx1CD31 2.5 (1.7–2.8) 3/9 10%–14%
AGM, VU4 11.5 Runx1CD31 22.0 (18.9–26.1) 4/9 10%–16%
AGM, VU 11.5 Flk1 10.0 (7.0–13.0) 8.8 (5.6–12.5) 1/8 3/9 13%–25%
AGM, VU 11.5 Flk1 85.1 (81.8–88.3) 74.0 (69.8–76.1) 3/7 4/9 12%–24%
AGM, VU4 11.5 Runx1Flk1 3.8 (2.9–5.8) 2/10 13%–21%
AGM, VU4 11.5 Runx1Flk1 19.8 (15.5–21.4) 2/8 14%–23%
AGM, VU 11.5 VE-Cad 2.7 (2.5–3.0) 7.4 (5.3–10.8) 4/17 6/10 9.6%–73.2%
AGM, VU 11.5 VE-Cad 95.6 (93.3–96.7) 82.1 (74.6–84.4) 0/17 4/10 8.3%–46.2%
AGM, VU4 11.5 Runx1 2.9 (2.4–3.5) 6/7 11%–21%
VE-Cad
AGM, VU4 11.5 Runx1 20.8 (19.2) 5/6 13%–22%
VE-Cad
Fetal Liver 12.5 CD31 17.3 (15.5–19.0) 18.1 (10.5–24.6) 13/15 10/10 48%–90%
Fetal Liver 12.5 CD31 81.1 (79.6–82.5) 67.9 (59.2–80.0) 0/9 0/10
Fetal Liver 12.5 Flk1 2.4 (2.2–2.5) 1/85
Fetal Liver 12.5 Flk1 97.2 6/6
Fetal Liver 12.5 VE-Cad 2.3 (1.5–3.0) 7.8 (5.8–9.6) 1/105 0/10
Fetal Liver 12.5 VE-Cad 97.3 (96.3–98.0) 83.3 (82.2–84.3) 10/10 8/10 27%–100%
1 One ee of AGM region and VU cells, or 0.1 ee of fetal liver cells (0.1–0.2 ee for Flk-1) was transplanted per recipient.
2 Reconstitution data were determined by PCR amplification of peripheral blood DNA at 1 and 4 months posttransplantation. Data are the
total of 41 experiments.
3 The extent of reconstitution for mice transplanted with Runx1lz/ donor cells was determined by FACS analysis of bone marrow. In all cases
multilineage reconstitution was also demonstrated.
4 Secondary transplants were performed, and reconstitution was demonstrated.
5 Although the purity of the Flk-1 and VE-Cad population was 98%, repopulation by contaminating Flk-1 and VE-Cad cells cannot be
ruled out.
in both Runx1lz/ and Runx1/ embryos (Figure 4C). versely, Runx1 was expressed in 20% of c-kit cells
(Figure 4A). The Runx1c-kit cells represented 4%–6%c-kit was expressed on approximately 14% of Runx1
cells in the AGM region and VU arteries, and con- of the total cells in these tissues. When we transplanted
Table 2. HSCs in Runx1lz/ Embryos Include Endothelial Cells and Mesenchymal Cells
# Reconstituted2
Embryonic Embryonic Cell
% of Total Viable Cells (Range)Tissue Age Population1 # Transplanted
Runx1/ Runx1lz/ Runx1/ Runx1lz/ % Reconstitution3
AGM, VU 11.5 CD31CD45 1.5 (1.2–1.8) 4/10 10%–18%
AGM, VU 11.5 CD31CD45 7.4 (6.8–8.1) 4/10 10%–14%
AGM, VU 11.5 VE-CadCD45 1.5 1.1 (1.0–1.3) 4/10 5/9 10%–13%
AGM, VU 11.5 VE-CadCD45 1.0 1.8 (1.4–2.4) 0/10 3/9 10%–22%
AGM, VU4 10.5 Runx1VE-Cad 2.2 0/4
and/or CD45
AGM, VU4 10.5 Runx1VE- 14.9 2/4 5%
CadCD45
AGM, VU4 11.5 Runx1VE-Cad 3.2 (1.9–3.9) 6/9 10%–14.5%
and/or CD45
AGM, VU4 11.5 Runx1VE- 19.0 (15.0–24.3) 6.9 10%–18%
CadCD45
AGM, VU 11.5 VE-Cad 3.4 5/7
and/or CD45
AGM, VU 11.5 VE-CadCD45 95.9 0/5
1 One ee of AGM region and VU cells was transplanted per recipient.
2 Reconstitution data were determined by PCR amplification of peripheral blood DNA at 1 and 4 months posttransplantation. Data are the
total of 10 experiments.
3 The extent of reconstitution for mice transplanted with Runx1lz/ donor cells was determined by FACS analysis of bone marrow. In all cases
multilineage reconstitution was also demonstrated.
4 Secondary transplants were performed and reconstitution demonstrated.
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Figure 4. Sca-1 and c-kit Expression on Runx1 HSCs
(A) Representative FACS profiles for E11.5 AGM region and VU artery cells from a Runx1lz/ embryo incubated with FDG and stained for
Sca-l or c-kit. Representative percentages of single-positive and double-positive cell types and sort regions are shown.
(B) Transverse section through the AGM region of an E11.5 Runx1lz/ embryo showing colocalization of c-kit (brown) and Runx1 (blue) in
endothelial (arrow) and mesenchymal (arrowhead) cells. Asterisks indicate two Runx1c-kit cells.
(C) Transplantation results: 1one ee of Runx1lz/ AGM region and VU cells was transplanted per recipient; 2 reconstitution data were determined
by PCR amplification of peripheral blood DNA at 1 and 4 months posttransplantation; 3 the extent of reconstitution for mice transplanted with
Runx1lz/ donor cells was determined by FACS analysis of bone marrow; in all cases multilineage reconstitution was demonstrated; 4 secondary
transplants were performed and reconstitution demonstrated; 5 data from Sanchez et al. (1996).
the Runx1c-kit and the Runx1c-kit cells, we found We also found that the first HSCs that emerge during
embryonic development are heterogeneous. SomeHSCs only in the double-positive population (Figure 4C).
Most of the Runx1c-kit cells in the AGM region of HSCs in the AGM region and VU arteries of Runx1lz/
embryos express cell surface CD45, some express onlyRunx1lz/ embryos were located in the endothelium, in
mesenchymal cells directly under the endothelium (Fig- endothelial markers, and some express neither hemato-
poietic nor endothelial markers. These conclusions areure 4B), and, based on individual staining patterns, in
intraaortic hematopoietic clusters (North et al., 1999; based on transplantation into adult mice and do not
address whether these or other cells contribute to HSCTakakura et al., 1998; Yokomizo et al., 2001), thus defin-
ing the location of HSCs in this tissue. populations in the developing embryo.
Partitioning of HSCs between CD45 and CD45Discussion
Cells Is Sensitive to Runx1 Dosage
The proportion of CD45 HSCs is higher in Runx1/Runx1 is required for definitive hematopoiesis (Okuda
et al., 1996; Sasaki et al., 1996; Wang et al., 1996a, than in Runx1lz/ embryos, especially in the fetal liver.
The reason for this is not known; it is possible that Runx11996b), and here we show that all HSCs in the AGM
region, VU arteries, and the fetal liver express Runx1. dosage affects the number of CD45 molecules on the
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Figure 5. Model for Runx1 Function in HSC
Emergence
Runx1 expression (blue nuclei) is initiated in
endothelial cells and mesenchymal cells in the
ventral aspect of the dorsal aorta soon after it
forms and later in CD45 intraaortic clusters
that differentiate from the Runx1 endothelium.
HSCs are found among the Runx1 endothelial,
mesenchymal, and CD45 cell populations in
Runx1lz/ embryos. The Runx1 endothelial
and mesenchymal cells are present in the ab-
sence of functional Runx1, but intraaortic clus-
ters fail to form. Runx1 function is also required
to maintain Runx1 expression in the hemogenic
endothelium (North et al., 1999).
cell surface, causing CD45lo cells to fall into the CD45 and VU arteries of E11.5 Runx1lz/ embryos is derived
from cells in the endothelium that do not express CD45gate. Alternatively, Runx1 dosage could affect the num-
but do express Runx1.ber of cells that express CD45. Since the size and num-
Runx1 dosage affects the number of endothelial HSCsber of intraaortic hematopoietic clusters is also report-
(defined as a CD31 or VE-Cad cell that is CD45), asedly smaller in Runx1lz/ embryos (Cai et al., 2000), we
CD45 HSCs were found in E11.5 Runx1/ embryos atbelieve the latter explanation is more likely. This inter-
a lower frequency than in Runx1lz/ embryos. In addition,pretation is consistent with our CD45 FACS profiles (Fig-
Runx1lz/ embryos contain a population of mesenchymalure 2B) and also with a report by Mukouyama et al.
HSCs that were not detected in E11.5 Runx1/ em-(2000) that in vitro cultures of dispersed AGM regions
bryos. One possible explanation for the presence offrom Runx1/ embryos contained significantly fewer
mesenchymal HSCs in Runx1lz/ embryos is that theCD45 cells than those from Runx1/ embryos. Our
expression of endothelial markers may be lower than indata do not address whether the CD45 HSCs in
wild-type embryos, causing Runx1 endothelial cells toRunx1lz/ embryos are all located within hematopoietic
fall into the CD31 or VE-Cad. We cannot rule out thisclusters or whether some are CD45CD31 cells scat-
possibility. However, we favor a model that reducedtered throughout the paraaortic mesenchyme, since we
Runx1 dosage affects the distribution of HSCs into thedid not directly test the activity of CD45CD31 cells.
CD45, endothelial, and mesenchymal cell pools. WeIn contrast, in E11.5 Runx1/ embryos, the majority of
hypothesize that it may do so by delaying the transitionHSCs in the AGM region and VU arteries are CD45
of the hemogenic endothelium to CD45 hematopoieticand also express the endothelial markers CD31 and VE-
clusters and possibly the differentiation of mesenchymalcadherin, suggesting that most HSCs are located within
cells into hemogenic endothelium. We speculate that thethe hematopoietic clusters.
Runx1 endothelial cells that might rapidly contribute to
the formation of a CD45 hematopoietic cluster by E11.5
Runx1 Endothelial Cells Are HSCs in a normal embryo may do so more slowly in a Runx1lz/
It has long been suggested that endothelial cells and embryo, and as a result, these endothelial HSCs accu-
hematopoietic cells share a common precursor, the bi- mulate in greater numbers. Similarly, the impairment in
potential hemangioblast. In support of this concept, sin- intraaortic cluster formation seen in Runx1lz/ embryos
gle “blast colony” cells isolated from embryonic stem (Cai et al., 2000) might delay the differentiation of Runx1
cell cultures gave rise to both endothelial cells and primi- mesenchymal cells into endothelial cells and/or their
tive erythrocytes in vitro (Choi et al., 1998). The emerging incorporation into the endothelium of the aortic wall,
view for definitive hematopoiesis is somewhat different. resulting in a detectable pool of mesenchymal Runx1
It has been proposed that definitive hematopoietic cells HSCs at E11.5. We speculate that reduced Runx1 dos-
may develop from a cell that is incorporated into the age might also delay the differentiation of an HSC into
endothelium of a blood vessel, as opposed to a bipoten- a hematopoietic progenitor cell. Such a delay would
tial hemangioblast precursor presumably of mesenchy- explain the results of Cai et al. (2000), who reported that
mal-like morphology (Jaffredo et al., 1998; Nishikawa et HSC emergence in the yolk sac is precocious (E10.5)
al., 1998). The data presented here demonstrate that and that HSC activity is higher in the AGM region at
Runx1lz/ embryos contain a population of HSCs that E10.5 in Runx1/ embryos than in wild-type embryos.
express cell surface VE-cadherin or CD31 but not CD45. We similarly detected more HSC activity in E10.5
VE-cadherin is a particularly good marker for endothe- Runx1lz/ embryos than was originally reported in /
lium, as it is concentrated at the adherens junctions of embryos (Mu¨ller et al., 1994) and estimate, based on
endothelial cells and is not found on mesenchymal cells the frequency of repopulation, that at E11.5 HSCs are
or round cells in the embryonic circulation (Breier et al., 2-fold more abundant in the AGM region and VU
1996; Nishikawa et al., 1998). Indeed, we showed that arteries in Runx1lz/ versus/ embryos. The concomi-
most HSCs have downregulated cell surface VE-cadh- tant decrease in committed progenitors in Runx1lz/ em-
erin once they reach the fetal liver. We conclude, there- bryos (Cai et al., 2000; Mukouyama et al., 2000; Wang
et al., 1996a, 1996b) is consistent with a model thatfore, that some of the HSC activity in the AGM regions
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Cell Preparationsreduced Runx1 dosage causes a delay in the HSC to
AGM regions, vitelline, and umbilical arteries or fetal livers wereprogenitor cell transition.
dissected from embryos. AGM regions and VU arteries were
pooled. The tissues were disaggregated with collagenase, as de-
scribed (de Bruijn et al., 2000, 2002). Tissues from Runx1/ andThe Role of Runx1 in HSC Emergence
Runx1lz/ embryos were pooled according to genotype.We previously reported that Runx1 is expressed in endo-
thelial cells and mesenchymal cells before hematopoi-
Fluorescent Antibody Staining and Flow Cytometryetic clusters are visible (North et al., 1999). In Runx1-
Dispersed cells from Runx1lz/ embryos were loaded with fluoresceindeficient embryos, a population of Runx1 endothelial
di--D-galactopyranoside (FDG, Molecular Probes) by hypotonic
cells and mesenchymal cells appear, but intraaortic he- shock and allowed to develop on ice, as described previously (North
matopoietic clusters fail to form, and endothelial cell et al., 1999). FDG was detected in the FITC channel of a FACStarPlus
(Becton-Dickinson). Background levels of fluorescence were deter-expression of Runx1 is prematurely extinguished. We
mined from FDG-loaded Runx1/ cells.concluded that Runx1 is required for the formation of
All antibodies used in this study were from Pharmingen. Eachintraaortic clusters and may act as a molecular switch,
antibody was either conjugated directly to PE (Phycoerythrin) or Cyspecifying the conversion from an endothelial to hema-
(CyChrome), or purified and detected with a PE- or Cy-labeled anti-
topoietic cell fate. Here, however, we show that Runx1 rat antibody. Background levels of fluorescence were determined
endothelial cells and mesenchymal cells also have HSC by incubation with PE or Cy isotype control antibodies (Pharmingen).
Antibodies used in the sorts include the following: c-kit (CD117;activity. This indicates that a hematopoietic cell fate is
2B8), CD31 (PECAM-1; MEC13.3), CD45 (30-F11), Flk-1 (VEGF-R2;already specified in a Runx1 mesenchymal or endothe-
Avas 12	1), VE-Cadherin (CD144; 11D4.1), and Sca-1 (Ly6A/E; D7lial cell. These Runx1 mesenchymal and endothelial
and E13-161.7). Antibody staining and sorting was performed bothcells emerge in Runx1-deficient animals but are unable
alone and in conjunction with FDG loading for Runx1 expression.
to progress to a CD45 hematopoietic cell (Figure 5). Single-cell suspensions were incubated with the appropriate anti-
The manifestation of this failure in situ is the lack of body or combinations of antibodies for 20 min on ice. Cells were
washed twice and incubated with a secondary antibody when re-cluster formation (North et al., 1999; Yokomizo et al.,
quired. Labeled cells were resuspended in PBS/FCS and run through2001) and the inability to provide long-term hematopoi-
the FACS sorter (FACStarPlus or FACS Vantage SE, Benton-Dickin-etic reconstitution upon transplantation (Cai et al., 2000).
son) using Hank’s Balanced Salt Solution (Gibco) in the sheath fluid,
a 100 
m nozzle, at a pressure of 9 or 14 psi with a flow rate of
1000 cells/second. Dead cells were excluded by Hoechst 33258Implications for Identifying HSCs
staining (Molecular Probes). Cells were sorted into 100% FCS; purityin Nonhematopoietic Tissues
ranged from 95%–99% for antibody sorts and 90%–95% for FDGRunx1 expression marks all HSCs in the embryonic he-
sorts.
matopoietic tissues and in the adult mouse bone marrow
(our unpublished data). One implication of our data is
Reconstitution Analysis
that all HSCs must express Runx1 at the time of trans- Two- to four-month-old 129S3/SvImJ x C57BL/6J F1 mice or C57BL/
plantation in order for hematopoietic reconstitution to 10 x CBA F1 mice were used as recipients for transplantation. Mice
were sublethally irradiated with a split dose of 900 rads from a 60Cooccur. A corollary hypothesis is that a Runx1 cell can-
or 137Cs source. Mice were maintained on sterile water supplementednot be induced to express Runx1 and acquire HSC activ-
with antibiotics following irradiation. Sorted cells were injected intoity following transplantation. If both are true, then Runx1
the tail vein of recipients along with 2  105 129S3/SvImJ x C57BL/may be a useful marker for locating HSCs in adult, non-
6J F1 or C57BL/10 x CBA F1 spleen cells to aid short-term survival.
hematopoietic tissues. Recent experiments showed that The number of cells in an embryo equivalent (ee) was determined
cells isolated from muscle or brain could contribute to by multiplying the number of cells per tissue, per embryo by the
fraction of positive or negative cells for each marker. Cell countsthe formation of blood (Bjornson et al., 1999; Jackson et
per tissue (mean  SD,  104 ) were 42.2  2.0, 53.7  3.9, andal., 1999). We predict that the cells in nonhematopoietic
270.2  66.4 for Runx1lz/ E10.5 AGMVU, E11.5 AGMVU, andtissues with HSC activity will be expressing Runx1 at
E12.5 fetal liver, respectively, and 46.8  9.5 and 250.1  38.1 forthe time of isolation, and that Runx1, in combination
Runx1/ E11.5 AGMVU and E12.5 fetal liver, respectively. The
with c-kit, will be a useful marker for locating these cells relative sizes of the sorted subsets are presented in the tables.
in muscle, brain, and potentially other tissues. Blood was collected at 1 and 4 months posttransplantation. Donor
cell contribution was determined by PCR of peripheral blood geno-
mic DNA using primers specific for lacZ (395bp), 5GCAGATGCACGExperimental Procedures
GTTACGATGC3 and 5GTGGCAACATGGAAATCGCTG3; human
-globin (428bp), 5CTTCAGGTTCCCAGTGAGGATG3 and 5GCTCEmbryo Generation
CCTAAGGGGTAAAGAGTG3; or neomycin resistance gene (neo)Embryos were generated from timed matings between genetically
sequences (880bp), 5GCTCAGAAGCAAAGACACAAA3 and 5GCCmarked male mice and wild-type female mice. Male mice used in this
TGCTTGCCGAATATCATG3. PCR for myogenin sequences (245bp),study were either Runx1lz/ (North et al., 1999), Ln72 (homozygous for
5TTACGTCCATCGTGGACAGC3 and 5TGGGCTGGGTGTTAGTCa human -globin transgene) (Strouboulis et al., 1992), or insulin
TTA3, was used to normalize DNA amounts between blood sam-receptor substrate 3-deficient (Irs3/) (Liu et al., 1999). Both
ples. The PCR products were visualized by ethidium bromide stain-Runx1lz/ and Irs3/ mice are of mixed 129S3/SvImJ and C57BL/6J
ing of agarose gels.backgrounds and were bred to129S3/SvImJ x C57BL/6J F1 females.
Ln72 mice are maintained on a mixed C57BL/10 and CBA back-
ground and bred to C57BL/10 x CBA F1 female mice. Detection of Multilineage Analysis and Secondary Transplantation
The total contribution of Runx1lz/ cells to repopulated bone marrowthe vaginal plug was designated as E0.5. Embryos were isolated
from the uterus at E10.5, E11.5, or E12.5 into phosphate-buffered was calculated based on the percentage of Runx1 (FDG) cells in
the bone marrow of transplant recipients compared to the percent-saline supplemented with 10% heat-inactivated fetal calf serum,
100 U/ml penicillin, and 100 
g/ml streptomycin (PBS/FCS). age of Runx1bone marrow cells in a Runx1lz/mouse. Bone marrow
was also examined for multilineage engraftment using FDG in com-Runx1/ and Runx1lz/ embryos were identified at the time of dis-
section by staining severed heads with X-gal (Sigma) as described bination with each of the following PE-conjugated lineage markers
(Pharmingen): T cells, Thy-1.2 (53-2.1); B-cells, CD45R/B220 (RA3-previously (North et al., 1999).
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6B2); myeloid cells, CD11b (Mac-1; M1/70); granulocytes, Gr-1 (Ly- Garcia-Porrero, J.A., Godin, I.E., and Dieterlen-Lie`vre, F. (1995). Po-
tential intraembryonic hemogenic sites at pre-liver stages in the6G; RB6-8C5); stem and progenitor cells, Sca-1 (Ly6A/E; D7). Incu-
bations and washes were performed as described for embryonic mouse. Anat. Embryol. 192, 425–435.
cells. Garcia-Porrero, J.A., Manaia, A., Jimeno, J., Lasky, L.L., Dieterlen-
Lie`vre, F., and Godin, I.E. (1998). Antigenic profiles of endothelial and
Immunohistology hemopoietic lineages in murine intraembryonic hemogenic sites.
E11.5 embryos were harvested and genotyped as described. The Develop., and Comp. Immunol. 22, 303–319.
caudal half of each embryo, including the vitelline and umbilical Hayashi, K., Natsume, W., Watanabe, T., Abe, N., Iwai, M., Okada,
arteries, was either prepared for paraffin sectioning, as described H., Ito, Y., Asano, M., Iwakura, Y., Habu, S., et al. (2000). Diminution
previously (North et al., 1999) or immersed in O.C.T. compound of the AML1 transcription factor function causes differential effects
(Tissue Tek) and flash frozen on dry ice with 95% ethanol. Specimen on the fates of CD4 and CD8 single-positive T cells. J. Immunol.
blocks were serially sectioned at 8 
m. Frozen sections were placed 165, 6816–6824.
on Superfrost slides (Fisher) and stored at 80C. Immunohisto-
Jackson, K.A., Mi, T., and Goodell, M.A. (1999). Hematopoietic po-chemistry with antibodies utilized in the sorts was performed on
tential of stem cells isolated from murine skeletal muscle. Proc. Natl.appropriate sections using the Vector Elite ABC kit (Vector labs).
Acad. Sci. USA 96, 14482–14486.Following antibody incubation and detection with DAB, the slides
Jaffredo, T., Gautier, R., Eichmann, A., and Dieterlen-Lie`vre, F.were stained overnight at 37C with X-gal and in some cases coun-
(1998). Intraaortic hemopoietic cells are derived from endothelialterstained with methyl-green (Vector labs).
cells during ontogeny. Development 125, 4575–4583.
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